News Listings

Takayama lab develops a better tool for studying cancer, new geometrically-inverted organoids

Georgia Tech has developed an automated and centralized system for replenishing PPE stock in research labs.

NIH-funded program to recruit thousands of participants to reveal impact of physical exercise at the molecular level

New cohort includes faculty from Georgia Tech, Emory, and Morehouse School of Medicine

Robles team develops a new tool to improve CBC and blood smear analysis

See list of recommended books, articles, movies, podcasts and tv shows

Fifteen Petit Institute faculty members recently joined the fight against the virus

Researchers utilize tools and techniques developed in Storici lab to unravel new features of genomic DNA

Coulter Department/Petit Institute faculty win support to advance research impacting human health

Astrobiologists are using their expertise to help produce necessary components for Covid-19 test kits in the state of Georgia.


In the News

Contrary to common medical guidance, chemotherapy does not appear to be the only culprit in neuropathy.
Georgia Tech faculty Pandarinath and Ting part of Emory-led focus on brain and behavior.
Study resumed into whether the malaria drug hydroxychloroquine could be effective in treating COVID-19.
Many experts are torn on the potential effectiveness of COVID-19, but a team of Georgia Tech researchers has found some serious side effects.
An optical mapping system in animal models show how the malaria drug creates serious disturbances in the electrical signals that govern heartbeat.
Researchers are developing an mHealth app that would allow providers to measure a patient's blood hemoglobin levels from a smartphone photograph of the inner eyelid.
A team including University of Georgia researchers has for the first time documented the regrowth of surgically removed pathways in the lymphatic system, a network of vessels designed to pump away inflammatory fluids and defend the body against infection.
NIH gives funds to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system and generate appropriate responses necessary to protect the general population against the virus
What is clear is that a poorly designed Georgia Department of Public Health (GaDPH) chart is illustrative of a larger problem
Emory and Georgia Tech researches evaluating coronavirus vaccine candidate effectiveness